BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Blok B, Van Kerrebroeck P, de Wachter S, Ruffion A, Van der Aa F, Jairam R, Perrouin-Verbe M, Elneil S. Three month clinical results with a rechargeable sacral neuromodulation system for the treatment of overactive bladder. Neurourol Urodyn 2018;37:S9-S16. [PMID: 29315785 DOI: 10.1002/nau.23465] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Holmes-martin K, Zhu M, Xiao S, Arab Hassani F. Advances in Assistive Electronic Device Solutions for Urology. Micromachines 2022;13:551. [DOI: 10.3390/mi13040551] [Reference Citation Analysis]
2 Girtner F, Burger M, Mayr R. [Sacral neuromodulation in under- and overactive detrusor-quo vadis? : Principles and developments]. Urologe A 2019;58:634-9. [PMID: 31139864 DOI: 10.1007/s00120-019-0949-7] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
3 Zhang Y, Zhang P, Tian X, Chen G, Li Y, Zhang Y, Xu Z, Wei Z, Zhang W, Ma L, Shi B, Liao L, Wang J. Remotely programmed sacral neuromodulation for the treatment of patients with refractory overactive bladder: a prospective randomized controlled trial evaluating the safety and efficacy of a novel sacral neuromodulation device. World J Urol 2019;37:2481-92. [PMID: 30809700 DOI: 10.1007/s00345-019-02698-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
4 Ammirati E, Giammò A, Manassero A, Carone R. Neuromodulation in urology, state of the art. Urologia 2019;86:177-82. [PMID: 31368415 DOI: 10.1177/0391560319866075] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
5 Coolen RL, Groen J, Blok B. Electrical stimulation in the treatment of bladder dysfunction: technology update. Med Devices (Auckl) 2019;12:337-45. [PMID: 31572023 DOI: 10.2147/MDER.S179898] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Noblett K, Crowder C. Neuromodulation. Obstet Gynecol Clin North Am 2021;48:677-88. [PMID: 34416945 DOI: 10.1016/j.ogc.2021.05.018] [Reference Citation Analysis]
7 De Wachter S, Knowles CH, Elterman DS, Kennelly MJ, Lehur PA, Matzel KE, Engelberg S, Van Kerrebroeck PEV. New Technologies and Applications in Sacral Neuromodulation: An Update. Adv Ther 2020;37:637-43. [PMID: 31875299 DOI: 10.1007/s12325-019-01205-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
8 Vaganée D, Kessler TM, Van de Borne S, De Win G, De Wachter S. Sacral neuromodulation using the standardized tined lead implantation technique with a curved vs a straight stylet: 2-year clinical outcomes and sensory responses to lead stimulation. BJU Int 2019;123:E7-E13. [DOI: 10.1111/bju.14650] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
9 Noblett KL, Buono K. Sacral Nerve Stimulation as a Therapy for Patients With Refractory Voiding and Bowel Dysfunction. Obstetrics & Gynecology 2018;132:1337-45. [DOI: 10.1097/aog.0000000000002968] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.8] [Reference Citation Analysis]
10 Blok B, Van Kerrebroeck P, de Wachter S, Ruffion A, Van der Aa F, Jairam R, Perrouin‐verbe MA, Elneil S. A prospective, multicenter study of a novel, miniaturized rechargeable sacral neuromodulation system: 12‐month results from the RELAX‐OAB study. Neurourology and Urodynamics 2019;38:689-95. [DOI: 10.1002/nau.23892] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
11 Vaganée D, Van de Borne S, Fransen E, Voorham J, Voorham‐van der Zalm P, De Wachter S. Repeatability of tools to assist in the follow up and troubleshooting of sacral neuromodulation patients using the sensory response. Neurourology and Urodynamics 2019;38:801-8. [DOI: 10.1002/nau.23925] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 Poole RL, Dale M, Morgan H, Oladapo T, Brookfield R, Morris R. Axonics Sacral Neuromodulation System for Treating Refractory Overactive Bladder: A NICE Medical Technologies Guidance. Appl Health Econ Health Policy 2021. [PMID: 34964090 DOI: 10.1007/s40258-021-00701-0] [Reference Citation Analysis]
13 Blok B, Van Kerrebroeck P, de Wachter S, Ruffion A, Van der Aa F, Perrouin-Verbe MA, Elneil S. Two-year safety and efficacy outcomes for the treatment of overactive bladder using a long-lived rechargeable sacral neuromodulation system. Neurourol Urodyn 2020;39:1108-14. [PMID: 32243625 DOI: 10.1002/nau.24317] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Marinkovic SP. New technologies in the management of overactive bladder: current research and future prospects. Ther Adv Urol 2019;11:1756287219844669. [PMID: 31040883 DOI: 10.1177/1756287219844669] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
15 Zhang Y, Meng L, Zhang P, Tian X, Chen G, Li Y, Zhang Y, Xu Z, Wei Z, Zhang W, Ma L, Shi B, Liao L, Wang J. Intermediate-term results of a prospective, multicenter study on remote programming sacral neuromodulation for refractory overactive bladder. Transl Androl Urol 2021;10:1966-75. [PMID: 34159077 DOI: 10.21037/tau-21-43] [Reference Citation Analysis]